Company Filing History:
Years Active: 1996-1997
Title: The Innovations of Stephen P Bell
Introduction
Stephen P Bell is a notable inventor based in Cold Spring Harbor, NY (US). He has made significant contributions to the field of molecular biology, particularly in the study of the origin of replication complex genes. With a total of 2 patents, his work has implications for understanding cell growth and developing pharmacological agents.
Latest Patents
Bell's latest patents focus on the Origin of Replication Complex (ORC) genes. These patents describe nucleic acids that encode ORC proteins and hybridization reagents, probes, and primers capable of hybridizing with ORC genes. The methods outlined in these patents involve screening chemical libraries for lead compounds that can be useful in diagnosing or treating diseases associated with undesirable cell growth. An exemplary screening process includes forming a mixture of a recombinant ORC protein, a natural intracellular ORC protein binding target, and a candidate pharmacological agent. The mixture is incubated under specific conditions to detect the binding of the ORC protein to the target, which is crucial for identifying potential therapeutic agents.
Career Highlights
Stephen P Bell has worked at prestigious institutions such as Cold Spring Harbor Laboratory and the University of California. His research has significantly advanced the understanding of replication processes in cells, contributing to the broader field of genetics and molecular biology.
Collaborations
Throughout his career, Bell has collaborated with esteemed colleagues, including Bruce W Stillman and Ryuji Kobayashi. These collaborations have further enriched his research and expanded the impact of his innovations.
Conclusion
Stephen P Bell's contributions to the field of molecular biology through his patents and research have paved the way for advancements in understanding cell growth and developing new therapeutic agents. His work continues to influence the scientific community and holds promise for future innovations.